You have read all your free articles, to continue reading subscribe to read the rest of this content.
On its first day on the Copenhagen stock market Friday, Novo Nordisk's newly public IT business got off to a fast start, with shares rising by as much as 44 percent, according to Reuters. Investors quickly bid up shares in NNIT, which had an offering price of 125 Danish kroner,…
The pharma company has lately announced several encouraging results from its ongoing clinical trials in lung cancer, gastric cancer, colorectal cancer and liver cancer. The Phase III ADAURA trial showed for example that treatment with Tagrisso after surgery with curative intent reduced the risk oAlready a subscriber Login You have…
Atrogi has been selected for a grant from Eurostars, an initiative of the European Commission that promotes research, and the intergovernmental innovation network EUREKA. The application was done in consortium with Stockholm University, Maastricht University, the Latvian Institute of Organic SyntAlready a subscriber Login You have read all your free…
Serendipity Partners (Serendipity) now owns 49% of the shares, however, Dr. Ola Gudmundsen will still hold the majority of the shares. The transaction is mainly structured as a share issue, where Serendipity provides growth capital to LINK Medical, states the company. Co-owners and long-term invAlready a subscriber Login You have…
